The evolution of therapeutic modalities drives the adoption of single-use technologies.

Review of SUT Adoption in Biopharma Manufacturing

Despite its understandable hesitancy, the pharma industry is facing a need for more widespread adoption of cloud-based solutions.

Why Are Pharmaceutical Companies Reluctant to Adopt Cloud Technologies?

Given the criticality of fill/finish processes, it is clear that automation is the next technological step.

 Automating the Future of Fill/Finish

Topic

Feliza Mirasol is the science editor for 

Articles

Christian Morello, vice president and head of the Bioconjugates Business Unit at Lonza, looks at what is involved in developing modern ADCs. 

A CDMO’s Perspective on Outsourcing Challenges for ADCs–Part 2

Videos

Christian Morello, vice president and head of the Bioconjugates Business Unit at Lonza, discusses the challenges and unmet needs in bringing ADCs to market. 

A CDMO’s Perspective on Outsourcing Challenges for ADCs–Part 1

Feb. 11, 2025 marks the 10th anniversary of the International Day of Women and Girls in Science.

The 10th Anniversary of the International Day of Women and Girls in Science

In a lead up to The International Day of Women and Girls in Science, Pharmaceutical Technology® takes a look at the unique perspective women bring to the use of artificial intelligence in the pharmaceutical industry.

Women, STEM, and AI in Pharma

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

These infections can be caused by certain Gram-negative microorganisms, making the infections challenging to control due to high antimicrobial resistance.

FDA Approves AbbVie Treatment for Complicated Intra-Abdominal Infections

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Application of AI/ML technology and a burst of M&A activity look to be shaping the future of the pharma industry.

Expanding Pharma’s Horizons Through AI and Acquisitions

Pharmaceutical Technology® sat down with Kate Coleman from Arriello to run through the major trends from 2024, including the importance of technological advances, and how these may progress in 2025.

Industry Outlook 2025: Regulating Technology for the Future

Webcasts

Webinar Date/Time: Tuesday, March 11, 2025 | 11:00 AM EDT / 3:00 PM GMT


Commercial Tech Transfers in OSD Manufacturing

A new bioanalytical lab being opened by Ardena at the site is expected to be operational by the third quarter of 2025.

Ardena Acquires Catalent Drug Product Manufacturing Facility in New Jersey

Cynthia A. Challener is a contributing editor to Pharmaceutical Technology.

Process consistency and robustness, analytical excellence, and regulatory compliance are essential in the scale-up of biosimilars.